Copyright
©The Author(s) 2020.
World J Radiol. Jun 28, 2020; 12(6): 87-100
Published online Jun 28, 2020. doi: 10.4329/wjr.v12.i6.87
Published online Jun 28, 2020. doi: 10.4329/wjr.v12.i6.87
Imaging considerations | Parameters |
Patient and equipment preparation | |
Patient preparation | No prerequisites, no fasting |
Position | Supine arms above shoulder or supported |
Scan | Rest scan |
Dose | 11C-PiB 10-20 mCi (370-740 MBq) IV[50] |
18F florbetapir 6 mCi (222 MBq) IV[51] | |
18F florbetaben 0.1 mCi/kg (4 MBq/kg) IV[52] | |
Time from injection to acquisition | 11C-PiB 30 min[50] |
18F florbetapir continuous over 60 min[51] | |
18F florbetaben continuous over 80 min[52] | |
Scan parameters | |
Field of view | Heart; Chest |
Image type | Low-dose (10 mA, 120 kVp, free tidal breathing) CT scout scan |
Low-dose CT transmission scan (10 mA, 120 kVp, free tidal breathing) over the heart | |
Emission scan 2D 40-60 mCi (1480-2220 MBq) | |
Emission scan 3D 10-20 mCi (370-740 MBq) | |
Matrix | 128 × 128-400 × 400 |
Reconstruction | Filtered back projection or iterative reconstruction |
- Citation: Wang TKM, Abou Hassan OK, Jaber W, Xu B. Multi-modality imaging of cardiac amyloidosis: Contemporary update. World J Radiol 2020; 12(6): 87-100
- URL: https://www.wjgnet.com/1949-8470/full/v12/i6/87.htm
- DOI: https://dx.doi.org/10.4329/wjr.v12.i6.87